Literature DB >> 33602978

Beta cell function, insulin resistance and vitamin D status among type 2 diabetes patients in Western Kenya.

Jamil Said1, David Lagat2, Allan Kimaina3, Chrispine Oduor2.   

Abstract

Serum vitamin D status exerts effects on glucose-insulin-homeostatic states underlying Diabetes-Mellitus, Type 2 (T2DM). This has been described in white and Asian population where low Vitamin D levels predicted future impairments in beta cell function and worsening of insulin resistance. This study aimed to examine the relationship between serum vitamin D, insulin resistance and beta cell function in a sub population of black Kenyan T2DM patients. The primary objective was to determine the levels of serum 25 hydroxy (25-OH) vitamin D, and estimate the insulin resistance, and beta cell function among T2DM patients at Moi Teaching and Referral Hospital (MTRH). This was a cross sectional study. 124 T2DM patients attending the MTRH Diabetes clinic between February and May 2016 were enrolled. Patients on insulin therapy and/or thiazolidinediones were excluded. Anthropometric, clinical and demographic data was obtained. Samples were drawn for estimation of serum 25-OH vitamin D, fasting insulin levels and fasting blood glucose levels. HOMA (Homeostatic model of assessment) model was used to estimate Beta cell secretion (HOMA-B) and insulin resistance (HOMA-IR); while the Disposition index {(DI) hyperbola product of insulin sensitivity (1/HOMA-IR) and beta cell secretion} was used to estimate the beta cell function. The relationships between serum vitamin D, insulin resistance and beta cell function were explored using a linear regression model. The study participants had a mean age of 56.2 (± 9.2) years, and a mean BMI of 26.9 kg/m2 (4.3). Forty nine percent (n = 61) were males. Vitamin D deficiency was present in 71.1% (n = 88) of the respondents. Relatively low levels of insulin resistance and higher levels of beta cell dysfunction were observed {median HOMA-IR of 2.3 (0.7, 6.5) and Disposition Index (DI) of 25.5 (14.3, 47.2)}. Vitamin D levels exhibited a low positive correlation with DI [r = 0.22 (95% CI: 0.03, 0.37)], but was not significantly correlated with HOMA-IR [r = 0.07(95% CI: - 0.11, 0.25)]. These results indicate that beta cell dysfunction rather than insulin resistance as the predominant defect among black T2DM patients seeking care at the MTRH diabetes clinic. Vitamin D deficiency is also prevalent among them and exhibits a low positive correlation with beta cell dysfunction. There was no correlation observed between Vitamin D deficiency and insulin resistance.

Entities:  

Mesh:

Substances:

Year:  2021        PMID: 33602978      PMCID: PMC7892854          DOI: 10.1038/s41598-021-83302-0

Source DB:  PubMed          Journal:  Sci Rep        ISSN: 2045-2322            Impact factor:   4.379


  38 in total

1.  Low levels of serum calcidiol in an African population compared to a North European population.

Authors:  Y Feleke; J Abdulkadir; R Mshana; T A Mekbib; L Brunvand; J P Berg; J A Falch
Journal:  Eur J Endocrinol       Date:  1999-10       Impact factor: 6.664

Review 2.  Blood biomarkers of vitamin D status.

Authors:  Joseph E Zerwekh
Journal:  Am J Clin Nutr       Date:  2008-04       Impact factor: 7.045

3.  Vitamin D status indicators in indigenous populations in East Africa.

Authors:  Martine F Luxwolda; Remko S Kuipers; Ido P Kema; E van der Veer; D A Janneke Dijck-Brouwer; Frits A J Muskiet
Journal:  Eur J Nutr       Date:  2012-08-10       Impact factor: 5.614

4.  Serum 25-hydroxyvitamin D, diabetes, and ethnicity in the Third National Health and Nutrition Examination Survey.

Authors:  Robert Scragg; MaryFran Sowers; Colin Bell
Journal:  Diabetes Care       Date:  2004-12       Impact factor: 19.112

Review 5.  Effect of vitamin D supplementation on glycaemic control and insulin resistance: a systematic review and meta-analysis.

Authors:  P S George; E R Pearson; M D Witham
Journal:  Diabet Med       Date:  2012-08       Impact factor: 4.359

6.  Hypovitaminosis D is associated with insulin resistance and beta cell dysfunction.

Authors:  Ken C Chiu; Audrey Chu; Vay Liang W Go; Mohammed F Saad
Journal:  Am J Clin Nutr       Date:  2004-05       Impact factor: 7.045

Review 7.  Role of vitamin D in the pathogenesis of type 2 diabetes mellitus.

Authors:  X Palomer; J M González-Clemente; F Blanco-Vaca; D Mauricio
Journal:  Diabetes Obes Metab       Date:  2008-03       Impact factor: 6.577

8.  Serum vitamin d status and its relationship to metabolic parameters in patients with type 2 diabetes mellitus.

Authors:  Jung Re Yu; Sang Ah Lee; Jae-Geun Lee; Gil Myeong Seong; Seong Joo Ko; Gwanpyo Koh; Mi-Hee Kong; Keun-Young Park; Byung-Joon Kim; Dong-Mee Lim; Dae Ho Lee
Journal:  Chonnam Med J       Date:  2012-08-24

Review 9.  Ethnic differences in the relationship between insulin sensitivity and insulin response: a systematic review and meta-analysis.

Authors:  Keiichi Kodama; Damon Tojjar; Satoru Yamada; Kyoko Toda; Chirag J Patel; Atul J Butte
Journal:  Diabetes Care       Date:  2013-06       Impact factor: 19.112

10.  Baseline serum 25-hydroxy vitamin d is predictive of future glycemic status and insulin resistance: the Medical Research Council Ely Prospective Study 1990-2000.

Authors:  Nita G Forouhi; Jian'an Luan; Andrew Cooper; Barbara J Boucher; Nicholas J Wareham
Journal:  Diabetes       Date:  2008-06-30       Impact factor: 9.461

View more
  2 in total

Review 1.  Effects of Probiotic Supplementation during Pregnancy on the Future Maternal Risk of Metabolic Syndrome.

Authors:  Aleksandra Obuchowska; Kamila Gorczyca; Arkadiusz Standyło; Karolina Obuchowska; Żaneta Kimber-Trojnar; Magdalena Wierzchowska-Opoka; Bożena Leszczyńska-Gorzelak
Journal:  Int J Mol Sci       Date:  2022-07-26       Impact factor: 6.208

2.  Clinical, metabolic, and immunological characterisation of adult Ugandan patients with new-onset diabetes and low vitamin D status.

Authors:  Davis Kibirige; Isaac Sekitoleko; Priscilla Balungi; Jacqueline Kyosiimire-Lugemwa; William Lumu
Journal:  BMC Endocr Disord       Date:  2022-09-15       Impact factor: 3.263

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.